Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion type Assertion NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_head.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion description "[In our study, both the MIB-1 labeling index (LI) and the proliferative index (% of cells in S + G2 + M phase) in fibrosarcomas were higher than those in cellular fibromas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_provenance.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion evidence source_evidence_literature NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_provenance.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion SIO_000772 8990141 NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_provenance.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion wasDerivedFrom befree-20150227 NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_provenance.
- NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_assertion wasGeneratedBy ECO_0000203 NP931301.RAFNvSj16_eMWtIgnfUdN8bW_ADP5uLUJsFDx5275CVE0130_provenance.